Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program
January 6, 2025 Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program
November 12, 2024 Asieris Unveils Results for the First Time at 2024 IPVC the Analysis of the of HPV Clearance Rate for Different HPV Types and Different Follow-up Times of the Non-Surgical Treatment for Cervical HSIL Product APL-1702 Clinical Study
November 7, 2024 Asieris Pharmaceuticals and China Women’s Development Foundation Sign Strategic Cooperation Agreement for ‘Fertility-Friendly Cervical Health Initiative’
November 6, 2024 Cancer Foundation of China and Asieris Pharmaceuticals Forge Strategic Partnership for Cervical Cancer Prevention and Control